|
시장보고서
상품코드
1789379
세계의 알레르기 주사 시장 : 질환별, 알레르겐 유형별, 면역요법 유형별, 제형별, 연령층별, 성별, 최종 사용자별, 유통 채널별, 지역별(2025-2032년)Allergy Shots Market, By Disease Indication, By Allergen Type, By Immunotherapy Type, By Formulation, By Age Group, By Gender, By End User, By Distribution Channel, By Geography |
||||||
세계의 알레르기 주사 시장 규모는 2025년 55억 2,000만 달러로 추정되고, 2032년까지 85억 8,000만 달러에 이를 것으로 예측되며, 예측 기간 중 연평균 성장률(CAGR) 6.5%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 55억 2,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 6.50% | 예측 금액(2032년) | 85억 8,000만 달러 |
세계의 알레르기 주사 시장은 면역 요법 중에서도 중요한 치료 분야이며, 세계의 알레르기 질환의 만연에 대응하고 있습니다. 알레르기 주사는 알레르겐 면역 요법 또는 피하 면역 요법(SCIT)으로도 알려져 있으며, 특정 알레르겐을 점진적으로 증가시켜 투여하고 환자를 감감작용하여 과민한 면역 반응을 억제합니다.
이 치료법은 계절성 알레르기, 다니아 알레르기, 반려동물 비듬 과민증, 곤충 독 알레르기 등 다양한 알레르기 증상의 장기적인 해결책으로 큰 지지를 얻고 있습니다. 이 시장에는 알레르기 증상을 지속적으로 완화하도록 설계된 다양한 알레르겐 추출물, 표준화 백신 및 특수 전달 시스템이 포함되어 있습니다. 도시화, 환경오염, 라이프스타일의 변화 등의 요인에 의해 알레르기 질환의 부담이 세계적으로 증가하는 가운데, 효과적인 면역요법 솔루션에 대한 수요는 증가의 길을 따라가고 있습니다. 건강 관리 제공업체와 환자 모두 단순히 증상을 관리하는 것이 아니라 근본 원인을 다루는 질병 변형 치료로서 알레르기 주사의 가치를 인식하고 있으며,이 시장은 향후 몇 년 동안 크게 성장할 것으로 예측됩니다.
시장 역학
세계의 알레르기 주사 시장은 현대 의료에서의 중요성의 확대를 뒷받침하는 몇 가지 주요 촉진요인에 의해 지원됩니다. 주요 촉진요인은 세계 알레르기 질환의 유병률의 상승이며, 알레르기 질환은 세계 인구의 약 25%에 영향을 미치고 효과적인 치료 솔루션을 필요로 하는 많은 환자를 생산하고 있다는 조사 결과가 나옵니다. 대증요법보다 면역요법이 장기적인 장점이 있다는 인식이 넓어졌고, 의료 종사자와 환자 모두 알레르기 주사를 바람직한 치료방법으로 채택하게 되었습니다. 또한, 알레르겐의 표준화와 정제 기술의 발전으로 알레르기 주사의 안전성과 효능에 대한 프로파일이 향상되어 의사의 신뢰와 환자의 수용성이 높아지고 있습니다.
개인화된 의료가 중요하게 되었다는 점도 알레르기 예방 주사를 개별 알레르겐 프로파일에 맞출 수 있기 때문에 시장 성장에 기여하고 있습니다. 그러나, 치료 기간이 보통 3-5년에 이르기 때문에 환자의 컴플라이언스나 어드히어런스가 저해될 가능성이 있는 등, 시장은 현저한 억제요인에 직면하고 있습니다. 아나필락시스를 비롯한 심각한 알레르기 반응의 위험은 신중한 모니터링과 전문적인 의료 환경을 필요로 하므로 일부 지역에서는 접근이 제한됩니다. 신흥국 시장에서는 치료비가 높고 보험 적용이 불충분한 것도 보급을 막는 추가 장벽이 되고 있습니다. 이러한 과제에도 불구하고 건강 관리 인프라가 개선되고 알레르기 질환에 대한 인식이 높아지는 신흥 시장에는 큰 비즈니스 기회가 존재합니다. 설하 면역요법 및 피부외 패치와 같은 신규 전달 시스템의 개발은 시장 확대의 기회를 제공합니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 알레르기 주사 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 출시와 승인, 시장 동향, 지역별 전망, 주요기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 알레르기 주사 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계의 알레르기 주사 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계의 알레르기 주사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 알레르기 주사 시장 : 질환별(2020-2032년)
- 알레르기성 비염
- 알레르기성 천식
- 아토피 피부염(습진)
- 독과민증
- 알레르기성 결막염
- 비용종을 수반하는 만성 부비동염
제5장 세계의 알레르기 주사 시장 : 알레르겐유형별(2020-2032년)
- 꽃가루
- 진드기
- 곰팡이
- 동물 비듬
- 곤충독
- 기타 식품 알레르겐
제6장 세계의 알레르기 주사 시장 : 면역요법 유형별(2020-2032년)
- 피하 면역요법(SCIT)
- 설하 면역요법(SLIT)
- 피부상 면역요법(EPIT)
- 경구 면역요법(OIT)
- 림프내 면역요법(ILIT)
제7장 세계의 알레르기 주사 시장 : 제형별(2020-2032년)
- 주사용 현탁액
- 드롭
- 태블릿
- 캡슐
- 경피 패치
제8장 세계의 알레르기 주사 시장 : 연령층별(2020-2032년)
- 소아
- 성인
제9장 세계의 알레르기 주사 시장 : 성별(2020-2032년)
- 여성
- 남성
제10장 세계의 알레르기 주사 시장 : 최종 사용자별(2020-2032년)
- 병원
- 알레르기 및 면역학 전문 클리닉
- 재택치료
- 기타(연구 및 학술 기관 등)
제11장 세계의 알레르기 주사 시장 : 유통 채널별(2020-2032년)
- 병원 약국
- 소매 약국
- 온라인 약국
제12장 세계의 알레르기 주사 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제13장 경쟁 구도
- ALK-Abello A/S
- HAL Allergy BV,
- Stallergenes Greer
- AllVac Pharmaceuticals
- Allergopharma(Merck KGaA)
- Roche
- Biomay AG
- LETIPharma
- Inmunotek SL
- Allergy Therapeutics
- Astellas Pharma Inc.
- DBV Technologies
- Anergis SA
- Circassia Pharmaceuticals
제14장 애널리스트의 제안
- 「운명의 고리」
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제15장 참고문헌과 조사방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Allergy Shots Market is estimated to be valued at USD 5.52 Bn in 2025 and is expected to reach USD 8.58 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 5.52 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.50% | 2032 Value Projection: | USD 8.58 Bn |
The global allergy shots market represents a critical therapeutic segment within the broader immunotherapy landscape, addressing the growing prevalence of allergic conditions worldwide. Allergy shots, also known as allergen immunotherapy or subcutaneous immunotherapy (SCIT), involve the administration of gradually increasing doses of specific allergens to desensitize patients and reduce their hypersensitive immune responses.
This treatment modality has gained significant traction as a long-term solution for various allergic conditions, including seasonal allergies, dust mite allergies, pet dander sensitivities, and insect venom allergies. The market encompasses a diverse range of allergen extracts, standardized vaccines, and specialized delivery systems designed to provide sustained relief from allergic symptoms. With the increasing burden of allergic diseases globally, driven by factors such as urbanization, environmental pollution, and changing lifestyle patterns, the demand for effective immunotherapy solutions continues to rise. Healthcare providers and patients alike are recognizing the value of allergy shots as a disease-modifying treatment that addresses root causes rather than merely managing symptoms, positioning this market for substantial growth in the coming years.
Market Dynamics
The global allergy shots market is propelled by several key drivers that underscore its expanding significance in modern healthcare. The primary growth driver is the escalating prevalence of allergic conditions worldwide, with studies indicating that allergic diseases affect approximately 25% of the global population, creating a substantial patient base requiring effective treatment solutions. Rising awareness about the long-term benefits of immunotherapy over symptomatic treatments has encouraged both healthcare providers and patients to adopt allergy shots as a preferred therapeutic approach. Additionally, advancements in allergen standardization and purification technologies have enhanced the safety and efficacy profiles of allergy shots, boosting physician confidence and patient acceptance.
The growing emphasis on personalized medicine has also contributed to market growth, as allergy shots can be tailored to individual allergen profiles. However, the market faces notable restraints including the lengthy treatment duration typically spanning 3-5 years, which may deter patient compliance and adherence. The risk of severe allergic reactions, including anaphylaxis, requires careful monitoring and specialized healthcare settings, limiting accessibility in certain regions. High treatment costs and inadequate insurance coverage in developing markets pose additional barriers to widespread adoption. Despite these challenges, significant opportunities exist in emerging markets where healthcare infrastructure is improving and awareness of allergic diseases is increasing. The development of novel delivery systems, such as sublingual immunotherapy and epicutaneous patches, presents opportunities for market expansion.
Key Features of the Study
- This report provides in-depth analysis of the global allergy shots market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global allergy shots market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include ALK-Abello A/S, HAL Allergy B.V.,, Stallergenes Greer, AllVac Pharmaceuticals, Allergopharma (Merck KGaA), Roche, Biomay AG, LETIPharma, Inmunotek S.L., Allergy Therapeutics, Astellas Pharma Inc., DBV Technologies, Anergis SA, and Circassia Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global allergy shots market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy shots market
Market Segmentation
- Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Allergic Rhinitis
- Allergic Asthma
- Atopic Dermatitis (Eczema)
- Venom Hypersensitivity
- Allergic Conjunctivitis
- Chronic Sinusitis with Nasal Polyps
- Allergen Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pollen
- Dust Mites
- Mold
- Animal Dander
- Insect Venom
- Other Food Allergens
- Immunotherapy Type Insights (Revenue, USD Bn, 2020 - 2032)
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Epicutaneous Immunotherapy (EPIT)
- Oral Immunotherapy (OIT)
- Intralymphatic Immunotherapy (ILIT)
- Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable Suspensions
- Drops
- Tablets
- Capsules
- Transdermal Patches
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adults
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Female
- Male
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Allergy and Immunology Specialty Clinics
- Homecare Settings
- Others (Research and Academic Institutions, etc.)
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Oline Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- ALK-Abello A/S
- HAL Allergy B.V.,
- Stallergenes Greer
- AllVac Pharmaceuticals
- Allergopharma (Merck KGaA)
- Roche
- Biomay AG
- LETIPharma
- Inmunotek S.L.
- Allergy Therapeutics
- Astellas Pharma Inc.
- DBV Technologies
- Anergis SA
- Circassia Pharmaceuticals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Allergy Shots Market, By Disease Indication
- Global Allergy Shots Market, By Allergen Type
- Global Allergy Shots Market, By Immunotherapy Type
- Global Allergy Shots Market, By Formulation
- Global Allergy Shots Market, By Age Group
- Global Allergy Shots Market, By Gender
- Global Allergy Shots Market, By End User
- Global Allergy Shots Market, By Distribution Channel
- Global Allergy Shots Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Allergy Shots Market, By Disease Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allergic Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Atopic Dermatitis (Eczema)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Venom Hypersensitivity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Sinusitis with Nasal Polyps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Allergy Shots Market, By Allergen Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pollen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dust Mites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mold
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Animal Dander
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Insect Venom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Food Allergens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Allergy Shots Market, By Immunotherapy Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Subcutaneous Immunotherapy (SCIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sublingual Immunotherapy (SLIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Epicutaneous Immunotherapy (EPIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral Immunotherapy (OIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intralymphatic Immunotherapy (ILIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Allergy Shots Market, By Formulation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Injectable Suspensions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transdermal Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Allergy Shots Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Allergy Shots Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Allergy Shots Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allergy and Immunology Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Research and Academic Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Allergy Shots Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oline Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Allergy Shots Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- ALK-Abello A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HAL Allergy B.V.,
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stallergenes Greer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AllVac Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergopharma (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biomay AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LETIPharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inmunotek S.L.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergy Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DBV Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Anergis SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Circassia Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
